Find clinical trials for Endometrial Cancer in New Haven, CT
CTV is a public benefit provided by Veeva Systems to help you find the most relevant clinical trials for you and your loved ones
Related conditions:
Endometrial Cancer trials near New Haven, CT, USA:
letrozole in advanced stage, persistent or recurrent endometrioid endometrial cancer at 6 months. Treatment will continue until eit...
Phase 2
New Haven, Connecticut, United States and 28 other locations
The purpose of this study is to evaluate the activity and safety profile of mirvetuximab soravtansine (IMGN853) in patients with type II endometrial...
Phase 2
New Haven, Connecticut, United States
This study will test whether the combination of radiation and Dostarlimab is an effective treatment for women with MMR-D/MSI-H endometrial c...
Phase 2
Commack, New York, United States and 6 other locations
tumor response in patients with persistent, recurrent or metastatic endometrial cancer harboring an ultra-mutated or hyper-mutated ...
Phase 2
New Haven, Connecticut, United States
Phase 1 trial to study the safety, pharmacokinetics and preliminary efficacy of STRO-002 given intravenously every 3 weeks.
Phase 1
New Haven, Connecticut, United States and 26 other locations
This study evaluates navtemadlin as maintenance treatment for patients with advanced or recurrent endometrial cancer (EC) who have ...
Phase 2, Phase 3
West Islip, New York, United States and 82 other locations
is an effective treatment for people with persistent or recurrent endometrial cancer or endometrial carcinosarcoma. The re...
Phase 2
Commack, New York, United States and 6 other locations
drug BMS-986205. Adding BMS-986208 to nivolumab could shrink the cancer or prevent it from returning, but it could also cause side effects....
Phase 2
Commack, New York, United States and 6 other locations
Uterine serous carcinoma (USC) accounts for up to 40% of endometrial cancer-related deaths. Patients with USC share many genomic an...
Phase 2
Greenlawn, New York, United States and 4 other locations
drug LY3484356 alone or in combination with other anticancer therapies is safe and effective in participants with advanced or metastatic breast cancer...
Phase 1
Commack, New York, United States and 75 other locations
Clinical trials
Research sites
Resources
Legal